Phenylethylamine Synthesis via Base-Free Hydrogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing phenylethylamine compounds, such as amphetamine, face challenges including the use of hazardous reagents, generation of by-products and impurities, reliance on controlled substances, and labor-intensive processes, which complicate large-scale manufacture and purification.
Innovation Solution
A method involving the reduction of a compound in the absence of acid or base, using gaseous hydrogen and a catalyst like palladium on carbon, followed by heating and acid addition to form a pharmaceutically acceptable salt, which avoids toxic reagents and by-products, and leverages mild reaction conditions for efficient large-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If norephedrine is converted to benzylic chloride to improve reduction ease, then the reduction becomes easier, but hazardous and corrosive reagents must be used
Solution Approach 1:
The patent extracts and removes the hazardous chlorination step from the synthesis pathway. Instead of converting norephedrine to benzylic chloride using hazardous reagents, the invention directly reduces norephedrine or uses safer alternative starting materials that eliminate the need for this dangerous intermediate step, while still achieving easy reduction conditions through other means.
Solution Approach 2:
The patent employs readily available, non-hazardous starting materials such as ephedrine and pseudoephedrine that can be obtained from natural sources or simple synthesis, replacing the need for hazardous reagents. These common compounds serve as disposable starting materials that eliminate the requirement for dangerous chemicals while maintaining process efficiency.
2Ease of manufacture
If norephedrine is converted to benzylic acetate to improve reduction ease, then the reduction becomes easier, but undesired acetamide by-products are generated
Solution Approach 1:
The patent removes the acetate protection group installation step from the synthesis pathway. By using ephedrine and pseudoephedrine as starting materials, the invention eliminates the need for acetate group installation and subsequent removal, thereby preventing acetamide by-product formation while maintaining easy reduction conditions through the inherent structure of the starting materials.
Solution Approach 2:
Instead of protecting the hydroxyl group as an acetate to facilitate reduction (which creates by-products), the invention inverts the approach by using starting materials where the hydroxyl group is already in a configuration that facilitates reduction without requiring protection. This reversal of the protection strategy eliminates the by-product issue.
3Adaptability or versatility
If phenylacetone is used as starting material to make amphetamines, then the synthesis route is available, but special storage and handling are required due to Schedule II designation and flammability
Solution Approach 1:
The patent extracts and removes phenylacetone from the synthesis pathway by using ephedrine and pseudoephedrine as alternative starting materials. This substitution eliminates the need to handle and store Schedule II controlled substances and highly flammable compounds, while still providing access to amphetamine synthesis through a different, safer route.
Solution Approach 2:
The invention uses readily available ephedrine and pseudoephedrine as disposable starting materials that can be obtained from natural sources or simple synthesis. These common compounds replace the hazardous phenylacetone, eliminating regulatory and safety issues while maintaining synthesis versatility.
4Productivity
If Raney Nickel is used to reduce imine derivative to produce amphetamines, then the reduction can be achieved, but various by-products and impurities are produced and Raney Nickel is pyrophoric requiring careful handling
Solution Approach 1:
The patent replaces the hazardous Raney Nickel catalyst with common, non-pyrophoric catalysts such as palladium on carbon or platinum oxide. These safer catalysts achieve the same reduction capability without the pyrophoric hazard and produce fewer by-products and impurities, eliminating the need for careful handling while maintaining productivity.
Solution Approach 2:
The invention changes the catalyst parameters from Raney Nickel to alternative catalysts with different physical and chemical properties. This parameter change maintains the reduction capability while eliminating pyrophoricity and reducing by-product formation, thereby improving safety and product purity without sacrificing productivity.
5Productivity
If Leukart-Wallach reaction is used between formamide or ammonium formate and phenylacetone, then amphetamines can be produced, but high temperatures are required and many by-products and impurities are produced
Solution Approach 1:
The patent removes phenylacetone from the synthesis pathway and uses ephedrine or pseudoephedrine as starting materials instead. This substitution eliminates the need for the high-temperature Leukart-Wallach reaction, as the reduction of ephedrine derivatives can be performed under milder conditions, thereby reducing energy requirements and by-product formation.
Solution Approach 2:
The invention changes the reaction parameters by using different starting materials that allow reduction to proceed at lower temperatures. By substituting ephedrine derivatives for phenylacetone, the reaction conditions can be modified to avoid high temperatures while maintaining amphetamine production efficiency and reducing impurity formation.
6Manufacturing precision
If phenylalanine is used to manufacture amphetamines to control stereochemistry, then stereochemistry can be controlled, but many steps are involved and hydride reagents or multiple catalytic hydrogenations are required
Solution Approach 1:
The patent uses ephedrine and pseudoephedrine as starting materials that already possess the desired stereochemistry from natural sources or simple synthesis. This preliminary establishment of stereochemistry eliminates the need for multiple steps including hydride reductions and catalytic hydrogenations required when starting from phenylalanine, thereby simplifying the process while maintaining stereochemical control.
Solution Approach 2:
The invention extracts and removes the complex multi-step sequence required when starting from phenylalanine. By using ephedrine derivatives with pre-established stereochemistry, the patent eliminates intermediate steps such as hydride reductions and multiple hydrogenations, streamlining the synthesis to a simpler process that maintains stereochemical integrity.
7Manufacturing precision
If dextroamphetamine is obtained by resolution of racemate through tartrate salt, then dextroamphetamine can be obtained, but the process is labour-intensive and low yield
Solution Approach 1:
The patent uses ephedrine and pseudoephedrine as starting materials that already contain the desired stereochemistry in pure enantiomeric form from natural sources. This preliminary possession of optical purity eliminates the need for resolution steps involving tartrate salts, thereby avoiding labor-intensive operations and low yields associated with racemate resolution, while directly producing the desired dextroamphetamine enantiomer.
8Ease of manufacture
If triethylamine is added to facilitate hydrogenation reaction of 1,3-oxazolidin-2-ones, then the hydrogenation can be facilitated, but triethylamine must be later removed in high vacuo and separation from amphetamine would be extremely difficult and expensive
Solution Approach 1:
The patent removes the triethylamine additive from the hydrogenation process by using ephedrine or pseudoephedrine as starting materials that do not require base catalysis for reduction. This elimination of triethylamine avoids the subsequent complex and expensive separation steps required to remove the amine from the amphetamine product, while still achieving effective hydrogenation through alternative mechanisms.
Solution Approach 2:
The invention uses straightforward, non-complex starting materials and conditions that do not require additional amine additives. By using ephedrine derivatives that can be reduced without triethylamine, the process avoids the need for expensive high-vacuum removal and complex separation operations, simplifying the overall manufacturing process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of phenylethylamines with minimal by-products, no need for separate purification, and is suitable for large-scale manufacture, maintaining the stereochemistry of starting materials, thus eliminating the need for resolution steps and reducing costs associated with handling hazardous substances.
Implementation Method 1
using gaseous hydrogen and a catalyst like palladium on carbon
Implementation Method 2
the reduction of a compound of formula A in at least one solvent in the absence of acid or base
Data Source
AI summary
A method of making a phenylethylamine of formula (B): wherein R2, R3, R4, R5, R6, Rα, Rβ and Rn are each independently selected from hydrogen, alkyl, acyl, aryl, amido, amino acids, sugars and nucleotides. The method includes the reduction of a compound of formula (A) in the absence of base: wherein R2, R3, R4, R5, R6, Rα, Rβ and Rn are as defined above.